WS #15714
Holding: newest synthesis is 4d 21h old
Mirum Pharmaceuticals reported that its drug Livmarli met its primary goal in a Phase 3 trial for rare liver diseases, providing a positive catalyst for the biotech sector. Separately, Morgan Stanley upgraded eBay to a top pick, citing the success of its live-commerce platform. These upgrades highlight specific alpha opportunities within the broader market stagnation.
Biotech and E-commerce Upgrades
Mirum Pharmaceuticals reported that its drug Livmarli met its primary goal in a Phase 3 trial for rare liver diseases, providing a positive catalyst for the biotech sector. Separately, Morgan Stanley upgraded eBay to a top pick, citing the success of its live-commerce platform. These upgrades highlight specific alpha opportunities within the broader market stagnation.